🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas R. Pieber

Medical University of Graz

ORCID: 0000-0003-3554-0405

Also affiliated with GrAT - Center for Appropriate Technology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
9.8Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Journal of Diabetes Science and Technology(2022)10.1177/19322968221085273
Top 2%
9.0DataRank
Top 2%282 citations

Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann +89 more

Papers

Driven by 7 papers — median percentile 86. Top paper: “A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings”.

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Journal of Diabetes Science and Technology(2022)10.1177/19322968221085273
Top 2%
9.0DataRank
Top 2%282 citations

Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann +89 more

Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE

BMJ Open Diabetes Research & Care(2021)10.1136/bmjdrc-2021-002339
N/A
2.1DataRank · unranked
48 citations

Edward Franek, Steven P. Marso, Thomas R. Pieber, Richard E. Pratley, Amoolya Gowda +3 more

Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial

BMJ Open Diabetes Research & Care(2020)10.1136/bmjdrc-2020-001649
N/A
1.6DataRank · unranked
36 citations

Bruce W. Bode, Ann Mertens, Young Min Cho, Erik Christiansen, CHRISTIN L. HERTZ +3 more

Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE

Diabetes Obesity and Metabolism(2020)10.1111/dom.14049
Top 26%
0.779DataRank
Top 26%14 citations

Ildiko Lingvay, Steven P. Marso, Athena Philis‐Tsimikas, Thomas R. Pieber, Neil R. Poulter +9 more

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)

UNC Libraries(2020)10.17615/6t97-gm41
N/A
0DataRank · unranked
0 citations

Richard E. Pratley, Kirstine Brown‐Frandsen, Steven P. Marso, Bernard Zinman, Neil R Poulter +8 more

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

UNC Libraries(2020)10.17615/9x50-7b68
N/A
0DataRank · unranked
0 citations

Martin Lange, Bernard Zinman, Kirstine Brown‐Frandsen, Darren K. McGuire, Scott S. Emerson +11 more

Tracking Ca2+ Dynamics in NOD Mouse Islets During Spontaneous Diabetes Development

Diabetes(2023)10.2337/db22-0952
N/A
0DataRank · unranked
13 citations

Johannes Pfabe, Srdjan Sarikas, Barbara Ehall, Thomas R. Pieber, Dean Korošak +3 more